For Implant Sciences (IMSC.PK), 2013 has proven to be the year where significant approvals, sales and achievements have led to a path of accelerated growth the company has been seeking for years. Put in words by the company's CEO Glenn Bolduc on the last conference call to investors, he reiterates that Implant Sciences a year ago and Implant Sciences today are two differentiated companies. Taking a closer look, we will examine what warrants the CEO to make these claims and review looming catalysts in the near term that could be a potential boon to the company and corresponding stock price.
Sales Penetrate All Time Highs: The Best Year in the Company's History
With revenues exceeding $12 million (10-K),...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|